CompareMarketResearchRequest a sample
Home / Healthcare / Pharmaceutical Glass

Healthcare · Market report

Pharmaceutical Glass Market Size, Share and Forecast 2026-2036

The global pharmaceutical glass market is worth USD 19.4 bn in 2026 and is forecast to reach USD 38.8 bn by 2036, growing at a 7.2% CAGR. United States is the largest country market and Vials is the largest by product segment.

USD 19.4 bnMarket size 2026
USD 38.8 bnForecast 2036
7.2%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global pharmaceutical glass market is worth USD 19.4 bn in 2026 and is forecast to reach USD 38.8 bn by 2036, growing at a 7.2% CAGR. United States is the largest country market and Vials is the largest by product segment.

ScopeGlass vials, ampoules, cartridges, syringe barrels and bottles made from borosilicate and soda-lime glass for packing injectables, vaccines and liquid medicines.
IndustryHealthcare
Value 2025USD 18.0 bn
Value 2026USD 19.4 bn
Value 2036USD 38.8 bn
CAGR 2026-20367.2%
Volume 202663,861 million pieces
Volume 2036115,870 million pieces
Average price 2026USD 0.30 per piece
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Pharmaceutical Glass market size and forecast, 2026-2036

Exhibit 1The global pharmaceutical glass market is forecast to grow from USD 19.4 bn in 2026 to USD 38.8 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 7.2%
Pharmaceutical Glass market value, 2025 to 2036Market value by year. 2025: USD 18.0 bn; 2026: USD 19.4 bn; 2027: USD 20.7 bn; 2028: USD 22.2 bn; 2029: USD 23.8 bn; 2030: USD 25.6 bn; 2031: USD 27.4 bn; 2032: USD 29.4 bn; 2033: USD 31.5 bn; 2034: USD 33.7 bn; 2035: USD 36.2 bn; 2036: USD 38.8 bn. Compound annual growth rate 2026 to 2036: 7.2%.202519.4 bn202627.4 bn203138.8 bn20367.2% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 19.4 bn
2027USD 20.7 bn
2028USD 22.2 bn
2029USD 23.8 bn
2030USD 25.6 bn
2031USD 27.4 bn
2032USD 29.4 bn
2033USD 31.5 bn
2034USD 33.7 bn
2035USD 36.2 bn
2036USD 38.8 bn

Pharmaceutical Glass market segmentation

By product

Exhibit 2Vials is the largest segment by product, with 36.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Pharmaceutical Glass market share by product, 2026Share of 2026 revenue by product. Vials: 36.0%; Cartridges and syringes: 26.0%; Bottles and jars: 20.0%; Ampoules: 10.0%; Other: 8.0%.Vials36.0%Cartridges and syringes26.0%Bottles and jars20.0%Ampoules10.0%Other8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Vials36.0%37.2%USD 7.0 bn7.5%
Ampoules10.0%7.1%USD 1.9 bn3.5%
Cartridges and syringes26.0%32.3%USD 5.0 bn9.5%
Bottles and jars20.0%16.3%USD 3.9 bn5.0%
Other8.0%7.2%USD 1.5 bn6.0%

By glass type

Exhibit 3Borosilicate Type I adds the most revenue by glass type, growing from USD 12.0 bn in 2026 to USD 25.6 bn by 2036Estimated revenue in USD by glass type, 2026 and 2036 forecast
Pharmaceutical Glass market by glass type, 2026 and 2036Revenue by glass type in 2026 and 2036. Borosilicate Type I: USD 12.0 bn in 2026, USD 25.6 bn in 2036, change +113%; Soda-lime Type III: USD 3.9 bn in 2026, USD 6.6 bn in 2036, change +72%; Treated soda-lime Type II: USD 3.5 bn in 2026, USD 6.6 bn in 2036, change +89%.20262036 forecastChangeBorosilicate Type I+113%12.0 bn25.6 bnSoda-lime Type III+72%3.9 bn6.6 bnTreated soda-lime Type II+89%3.5 bn6.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Borosilicate Type I62.0%65.9%USD 12.0 bn7.9%
Treated soda-lime Type II18.0%16.9%USD 3.5 bn6.6%
Soda-lime Type III20.0%17.1%USD 3.9 bn5.6%

By drug type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Generic injectables32.0%27.0%USD 6.2 bn5.4%
Biologics24.0%29.0%USD 4.6 bn9.2%
Vaccines20.0%23.0%USD 3.9 bn8.7%
Oral and topical liquids14.0%12.0%USD 2.7 bn5.6%
Diagnostics and others10.0%9.0%USD 1.9 bn6.1%

By surface treatment

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Uncoated56.0%50.0%USD 10.8 bn6.0%
Silicone treated20.0%18.0%USD 3.9 bn6.1%
Barrier coated16.0%22.0%USD 3.1 bn10.7%
Ammonium sulfate treated8.0%10.0%USD 1.5 bn9.6%

By buyer

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Branded pharma36.0%34.0%USD 7.0 bn6.6%
Generic makers34.0%29.0%USD 6.6 bn5.5%
Fill-finish contractors22.0%27.0%USD 4.3 bn9.4%
Biotech and diagnostics8.0%10.0%USD 1.5 bn9.6%

Top 25 countries for pharmaceutical glass by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 73.0% of 2026 revenue and the 25 countries below together hold 91.9%.

Exhibit 4United States is the largest country market at USD 4.5 bn in 2026, and the three largest countries hold 46.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Pharmaceutical Glass market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 4.5 bn, 23.0%; China: USD 2.9 bn, 15.0%; India: USD 1.5 bn, 8.0%; Germany: USD 1.2 bn, 6.0%; Japan: USD 968 mn, 5.0%; Italy: USD 774 mn, 4.0%; France: USD 677 mn, 3.5%; Brazil: USD 580 mn, 3.0%; United Kingdom: USD 580 mn, 3.0%; South Korea: USD 484 mn, 2.5%.United States4.5 bn 23.0%China2.9 bn 15.0%India1.5 bn 8.0%Germany1.2 bn 6.0%Japan968 mn 5.0%Italy774 mn 4.0%France677 mn 3.5%Brazil580 mn 3.0%United Kingdom580 mn 3.0%South Korea484 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 4.5 bn23.0%USD 8.3 bn6.4%
2ChinaUSD 2.9 bn15.0%USD 6.8 bn8.9%
3IndiaUSD 1.5 bn8.0%USD 4.0 bn9.9%
4GermanyUSD 1.2 bn6.0%USD 2.0 bn5.5%
5JapanUSD 968 mn5.0%USD 1.6 bn4.8%
6ItalyUSD 774 mn4.0%USD 1.4 bn5.8%
7FranceUSD 677 mn3.5%USD 1.2 bn5.9%
8BrazilUSD 580 mn3.0%USD 1.2 bn7.5%
9United KingdomUSD 580 mn3.0%USD 1.0 bn6.1%
10South KoreaUSD 484 mn2.5%USD 970 mn7.2%
11MexicoUSD 468 mn2.4%USD 939 mn7.2%
12SwitzerlandUSD 468 mn2.4%USD 939 mn7.2%
13SpainUSD 410 mn2.1%USD 725 mn5.9%
14CanadaUSD 331 mn1.7%USD 586 mn5.9%
15RussiaUSD 281 mn1.4%USD 496 mn5.9%
16PolandUSD 244 mn1.3%USD 613 mn9.7%
17IndonesiaUSD 219 mn1.1%USD 547 mn9.6%
18TurkeyUSD 197 mn1.0%USD 496 mn9.7%
19NetherlandsUSD 180 mn0.9%USD 318 mn5.9%
20AustraliaUSD 166 mn0.9%USD 295 mn5.9%
21BelgiumUSD 155 mn0.8%USD 275 mn5.9%
22ThailandUSD 145 mn0.8%USD 365 mn9.7%
23Saudi ArabiaUSD 137 mn0.7%USD 345 mn9.7%
24ArgentinaUSD 130 mn0.7%USD 326 mn9.7%
25TaiwanUSD 124 mn0.6%USD 217 mn5.8%
Rest of worldUSD 1.6 bn8.1%USD 2.9 bn6.2%
Exhibit 5China and United States account for 40% of the USD 19.4 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Pharmaceutical Glass market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 19.4 bn. China: +USD 3.9 bn; United States: +USD 3.8 bn; India: +USD 2.4 bn; Germany: +USD 817 mn; Brazil: +USD 622 mn; 20 other countries: +USD 6.5 bn; Rest of world: +USD 1.3 bn. Market value 2036: USD 38.8 bn.Market value 202619.4 bnChina+3.9 bnUnited States+3.8 bnIndia+2.4 bnGermany+817 mnBrazil+622 mn20 other countries+6.5 bnRest of world+1.3 bnMarket value 203638.8 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • SCHOTT Pharma
  • Gerresheimer
  • Corning
  • Stevanato Group
  • Nipro

Group 2: Regional and specialist players

  • SGD Pharma
  • Bormioli Pharma
  • Piramal Glass
  • Shandong Pharmaceutical Glass
  • DWK Life Sciences
  • Sisecam
  • Linuo Group
  • Cangzhou Four-Star Glass

Group 3: Emerging and niche players

  • Borosil
  • Neubor Glass
  • Kapoor Glass
  • Haldyn Glass

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pharmaceutical glass market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.2% is calculated from the resulting values.

The market is divided by product, by glass type, by drug type, by surface treatment, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the pharmaceutical glass market?

The global pharmaceutical glass market is estimated at USD 18.0 bn in 2025 and USD 19.4 bn in 2026.

How fast will the pharmaceutical glass market grow?

It is forecast to reach USD 38.8 bn by 2036, a compound annual growth rate of 7.2% from 2026, an increase of USD 19.4 bn.

Which country is the largest market for pharmaceutical glass?

United States is the largest market by revenue at USD 4.5 bn in 2026, 23.0% of the global total. The three largest countries together hold 46.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.9% a year from 2026 to 2036.

Which pharmaceutical glass segment is largest?

In the by product split, Vials is the largest segment with 36.0% of 2026 revenue.

Who are the leading pharmaceutical glass companies?

Global leaders include SCHOTT Pharma, Gerresheimer, Corning, Stevanato Group.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Pharmaceutical Filtration Pharmaceutical Labeling →

All Healthcare markets →

Request a sample